Boston, MA 03/25/2014 (wallstreetpr) – Galectin Therapeutics Inc (OTCBB:PRWP) posted a wider than expected net loss of $21.9 million compared to consensus estimates of $10.9 million in 2013. The increase in net loss was attributed to a non-cash charge related to modifications of certain warrants that amounted to $$8.8 million. Full year net loss also included $1 […]
